Search for: "Unit, Inc., Appeal of" Results 3621 - 3640 of 13,891
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Oct 2018, 3:50 am by Edith Roberts
” At Crime & Consequences, Kent Scheidegger observes that United States v. [read post]
30 Oct 2018, 2:00 am by DONALD SCARINCI
Cougar Den Inc.: An 1855 treaty between the United States and the Yakama Indian Nation provides members of the tribe “the right, in common with citizens of the United States, to travel upon all public highways. [read post]
29 Oct 2018, 12:20 pm by Steven Boutwell
HAECO Americas, Inc., 2018 WL 5312193 (M.D.N.C., 2018). [read post]
28 Oct 2018, 12:53 pm by Stuart Kaplow
In the United States Courts Of Appeals for the Eleventh Circuit, No. 17-11589, filed October 19, 2018. [read post]
27 Oct 2018, 10:00 pm
ENTHONE, INC., came out from the Court of Appeal of the Federal Circuit (CAFC) last Friday, and reminded me of a good tip: include evidence in the record to show that the claims relate to an unpredictable art. [read post]
26 Oct 2018, 7:29 am by Dennis Crouch
From the USPTO: The United States Patent and Trademark Office (USPTO) has published a Request for Comments (RFC) about a proposed procedure for motions to amend filed in inter partes reviews, post-grant reviews, and covered business method patent reviews (collectively AIA trials) before the Patent Trial and Appeal Board (PTAB). [read post]
25 Oct 2018, 9:13 am by Eugene Volokh
" The First Amendment to the United States Constitution demands that we not treat such speech-based injunctions so lightly. [read post]
24 Oct 2018, 4:39 pm by Joy Waltemath
In its brief in opposition, the DOJ also wrote, “To be sure, the United States disagrees with the court of appeals’ decision. [read post]
24 Oct 2018, 4:33 pm by Kevin LaCroix
John Reed Stark Most readers are undoubtedly familiar with the concept of “insider trading” – that is, the purchase or sale by company insiders of their personal holdings in company shares based on material non-public information. [read post]
24 Oct 2018, 9:16 am by Lawrence B. Ebert
From the decision:This appeal arises from an interference proceeding1 atthe United States Patent and Trademark Office, PatentTrial and Appeal Board (Board) and involves a treatmentmethod for multiple sclerosis with a particular dailydosage—480 mg—of fumaric acid esters (fumarates).Appellee Biogen MA, Inc. [read post]